SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (5220)12/31/1997 5:41:00 PM
From: William L. Molair II  Respond to of 17367
 
How quickly would you expect to hear results from the Phase II liver trial - weeks or months?

Sure wish that we could get a defintive answer on the H&Q conference participation.



To: Robert K. who wrote (5220)12/31/1997 5:51:00 PM
From: aknahow  Read Replies (2) | Respond to of 17367
 
Bob, knowing how much you like analyst I think you would enjoy seeing how poorly most of the 11 listed by F.J. Abella did. BTW XOMA was only on MacCamants list not Murphys' since performance is given as Jan 2 - Dec 30 1997.

westergaard.com:8080/Med/new.htm



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News